DV
Dividend Vision

INNPF — InnoCan Pharma Corporation

InnoCan Pharma Corporation (INNPF)

Its deepest 1-year drawdown was 98.5%.

InnoCan Pharma Corporation is an equity stock in the healthcare sector. The fund holds no distribution history and carries no reported expense ratio or assets under management data, indicating it may be a micro-cap or thinly traded security rather than a traditional dividend-focused ETF. This holding appeals primarily to investors seeking exposure to pharmaceutical and healthcare innovation rather than those prioritizing regular income distributions.

INNPF key facts

Asset type
Stock
Asset class
Equity
Inception date
04/09/2019
Distribution frequency
None
Last close
$1.58
Market cap
$7,108,060
Average volume
100.0
Beta
-0.219
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.34